{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:12:21Z","timestamp":1778713941034,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrc.2026.153693","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:48:03Z","timestamp":1774630083000},"page":"153693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["YEATS2\/TAK1 axis mediates TGF-\u03b21 driven adaptive resistance to sorafenib in hepatocellular carcinoma"],"prefix":"10.1016","volume":"817","author":[{"given":"Lizhi","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4085-0487","authenticated-orcid":false,"given":"Rongbin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153693_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41571-023-00816-4","article-title":"Biomarkers for immunotherapy of hepatocellular carcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.153693_bib2","article-title":"Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma","author":"Zhao","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.153693_bib3","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1111\/liv.15130","article-title":"Treatment and the prognosis of hepatocellular carcinoma in Asia","volume":"42","author":"Torimura","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2026.153693_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153693_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-025-02282-z","article-title":"D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma","volume":"10","author":"Pedretti","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153693_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153693_bib7","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.3748\/wjg.v28.i36.5250","article-title":"Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma","volume":"28","author":"Devan","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.153693_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","article-title":"TGF-\u03b21-Induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12","volume":"167","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153693_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41392-024-01887-0","article-title":"Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression","volume":"9","author":"Peng","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.153693_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.06.019","article-title":"Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma","volume":"367","author":"Chen","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153693_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104765","article-title":"Insights into Sorafenib resistance in hepatocellular carcinoma: mechanisms and therapeutic aspects","volume":"212","author":"Yousef","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2026.153693_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10091889","article-title":"Combined inhibition of TGF-\u03b21-Induced EMT and PD-L1 silencing Re-Sensitizes hepatocellular carcinoma to sorafenib treatment","volume":"10","author":"Shrestha","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.153693_bib13","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2026.153693_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jcmgh.2021.04.016","article-title":"TAK1 is a novel target in hepatocellular carcinoma and contributes to sorafenib resistance","volume":"12","author":"Xia","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153693_bib15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/0008-5472.CAN-19-3652","article-title":"Targeting the SAGA and ATAC transcriptional coactivator complexes in MYC-driven cancers","volume":"80","author":"Mustachio","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153693_bib16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-017-01173-4","article-title":"YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer","volume":"8","author":"Mi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.153693_bib17","article-title":"High expression of YEATS2 as a predictive factor of poor prognosis in patients with hepatocellular carcinoma","volume":"14","author":"Du","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153693_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/1541-7786.MCR-24-0060","article-title":"TEAD2 promotes hepatocellular carcinoma development and sorafenib resistance via TAK1 transcriptional activation","volume":"22","author":"Zhang","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153693_bib19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jcmgh.2021.06.005","article-title":"A novel atTAK against hepatocellular carcinoma: overcoming resistance to sorafenib","volume":"12","author":"Pietrobono","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153693_bib20","article-title":"The value of acetylation reader YEATS2 in hepatocellular carcinoma management","volume":"15","author":"Shi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153693_bib21","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.3390\/curroncol28030200","article-title":"Dual targeting of sorafenib-resistant HCC-derived cancer stem cells","volume":"28","author":"Shrestha","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbrc.2026.153693_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.639779","article-title":"Changes in wnt and TGF-\u03b2 signaling mediate the development of regorafenib resistance in hepatocellular carcinoma cell line HuH7","volume":"9","author":"Karabicici","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbrc.2026.153693_bib23","doi-asserted-by":"crossref","first-page":"W322","DOI":"10.1093\/nar\/gkz397","article-title":"HawkDock: a web server to predict and analyze the protein-protein complex based on computational docking and MM\/GBSA","volume":"47","author":"Weng","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2026.153693_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.153693_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3349\/ymj.2017.58.5.899","article-title":"Down-regulation of TGF-\u03b2 expression sensitizes the resistance of hepatocellular carcinoma cells to sorafenib","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.bbrc.2026.153693_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/mc.22592","article-title":"TGF\u03b2 signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells","volume":"56","author":"Ungerleider","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbrc.2026.153693_bib27","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1158\/1078-0432.CCR-14-1954","article-title":"High serum transforming growth Factor-\u03b21 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib","volume":"21","author":"Lin","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.153693_bib28","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1007\/s10620-012-2550-4","article-title":"TGF-\u03b21 secreted by hepatocellular carcinoma induces the expression of the Foxp3 gene and suppresses antitumor immunity in the tumor microenvironment","volume":"58","author":"Wang","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2026.153693_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000438631","article-title":"Hepatocellular carcinoma cells induce regulatory T cells and lead to poor prognosis via production of transforming growth Factor-\u03b21","volume":"38","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2026.153693_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"352","author":"Fan","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.153693_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12885-025-13435-2","article-title":"TGF-\u03b2 signaling orchestrates cancer-associated fibroblasts in the tumor microenvironment of human hepatocellular carcinoma: unveiling insights and clinical significance","volume":"25","author":"Ge","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrc.2026.153693_bib32","article-title":"Overexpression of YEATS2 remodels the extracellular matrix to promote hepatocellular carcinoma progression via the PI3K\/AKT pathway","volume":"15","author":"Liu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153693_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-025-03797-9","article-title":"YEATS2: a novel cancer epigenetic reader and potential therapeutic target","volume":"25","author":"Ji","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2026.153693_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fonc.2019.00474","article-title":"The MAP3K7-mTOR axis promotes the proliferation and malignancy of hepatocellular carcinoma cells","volume":"9","author":"Cheng","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2026.153693_bib35","article-title":"TAK1 deficiency promotes liver injury and tumorigenesis via ferroptosis and macrophage cGAS-STING signalling","volume":"5","author":"Su","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.bbrc.2026.153693_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991052","article-title":"Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: mechanistic insights","volume":"13","author":"Tian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153693_bib37","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1073\/pnas.0909781107","article-title":"Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis","volume":"107","author":"Inokuchi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2026.153693_bib38","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2026.153693_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29374","article-title":"Deciphering the role of non-coding RNAs involved in sorafenib resistance","volume":"10","author":"Jing","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.153693_bib40","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41417-025-00937-1","article-title":"Combined downregulation of TGF-\u03b21 and GRP78 is responsible for overcoming acquired sorafenib resistance, which is initiated by rewiring the cell surface CD44-GRP78-IGF-1R signaling circuit","volume":"32","author":"Li","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2026.153693_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbrc.2020.07.012","article-title":"Neddylation promotes protein translocation between the cytoplasm and nucleus","volume":"529","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."}],"updated-by":[{"DOI":"10.1016\/j.bbrc.2026.153863","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000}},{"DOI":"10.1016\/j.bbrc.2026.153863","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000}}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26004572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:13:33Z","timestamp":1777310013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26004572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":41,"alternative-id":["S0006291X26004572"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153693","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YEATS2\/TAK1 axis mediates TGF-\u03b21 driven adaptive resistance to sorafenib in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153693"}}